Toronto, Canada (PRWEB) September 07, 2012
Current estimates are that more than 30% of orally delivered new medicines need solubilization technology to achieve efficacy. Selecting the appropriate technology can result in non-crystalline, physically stable intermediates that will then be incorporated into immediate-release or modified release dosage forms.
This webinar will encompass key spray-dried dispersion (SDD) aspects that enhance and sustain in vivo drug solubility, and how these attributes are preserved during downstream solid dosage form formulation and process development. Discussions will include bulk-sparing tablet formulation and process development for pre-clinical studies, process development and scale-up strategies for clinical trial material manufacturing, and incorporation of SDD formulations into select modified-release dosage forms.
For more information or to register go to http://xtks.in/xto-508.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Karen Lim (416) 977-6555 ext 227